Tang, Chih-Hsin <br/><br/>
Research of Pathogenesis and Novel Therapeutics in Arthritis 

<br/><br/><br/>English[eng] 
<br/><br/><label>Subjects--Topical Terms: </label><br/>receptor activator of nuclear factor ?B||infliximab||tripterine||triptolide||osteoblast||tumor necrosis factor-alpha||synovial cell||anti-arthritis||biosimilars||Epstein-Barr virus||cytokines||SOX9||parathyroid hormone||nitric oxide||rat||etanercept||angiogenesis||glycosylation||mitogen activated protein kinase||Th9 lymphocytes||rheumatoid arthritis||IL-6||clodronate||bone erosion||mesenchymal stem cells||collagen-induced arthritis||biological||gene expression||inflammatory arthritis||osteoarthritis||fraxinellone||nuclear factor kappa B||messenger RNA||inflammation||miRNA||disease-modifying||adipokines||WNT||glycoprotein 42||miR-199a-5p||proliferation||next-generation sequencing||collagen||osteoarthritis (OA)||experimental arthritis||bone morphogenetic protein||TNF-?||computational modeling||basic research||osteoclast||therapeutics||certolizumab pegol||chondrocytes||progenitor cells||adjuvant arthritis||adalimumab||triterpenoid||sclareol||TNF?||fibroblast growth factor 2||antibodies||osteoblasts||molecular pathology||Th17||immunology||obesity||visfatin||articular cartilage||autoimmune||biomarkers||celastrol||MAPK||disease pathways||IL1?||arthritis||bioinformatics||anticitrullinated peptide antibodies||drug delivery system||antagonists||shared epitope||pathology||SMA- and MAD-related protein||small-molecule inhibitor||transforming growth factor ?||mice||golimumab||spinal fusion||antirheumatic drug||early osteoarthritis||stem cell||rheumatoid factor||therapeutic antibody||bisphosphonate||osteoclastogenesis||interleukin||spondyloarthropathies||clinical translation||therapy||Traditional Chinese medicine||chemokines||structure||cell signaling||microRNA